Levy M
Can J Physiol Pharmacol. 1978 Jun;56(3):511-4. doi: 10.1139/y78-077.
In marked contradistinction to the normal dog, to the dog with renal hypoperfusion, or to the chronic caval dog with ascites, the intravenous infusion of glucagon at 5 microgram/min to dogs with experimental portal cirrhosis and ascites does not increase glomerular filtration rate or renal blood flow. In eight experimental dogs who did not respond to glucagon, a marked natriuresis was observed in response to furosemide and a marked renal vasodilator response was seen following the intraarterial infusion of acetylcholine. Because plasma immunoreactive glucagon levels are increased fivefold in cirrhotic dogs, it is suggested that continuous high levels of this peptide render the animals insensitive to the effects of an exogenous infusion.
与正常犬、肾灌注不足的犬或伴有腹水的慢性腔静脉犬明显不同的是,以每分钟5微克的速度向患有实验性门脉性肝硬化和腹水的犬静脉输注胰高血糖素,并不会增加肾小球滤过率或肾血流量。在8只对胰高血糖素无反应的实验犬中,观察到速尿引起明显的利钠作用,动脉内输注乙酰胆碱后出现明显的肾血管舒张反应。由于肝硬化犬血浆免疫反应性胰高血糖素水平增加了五倍,因此提示这种肽的持续高水平使动物对外源性输注的作用不敏感。